SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors rally centers on the pending FDA decision on deramiocel for Duchenne muscular dystrophy, with traders reacting to managements confidence, the applications final-review status, and analyst upgrades. Many are bullish and speculate about short covering, while others stress that approval is uncertain and a rejection could bring significant downside.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

FIGR is drawing attention amid sharp price swings and debate over whether its growth in HELOC lending and blockchain-based financial infrastructure justifies its valuation. Bears point to insider selling and persistent weakness, while bulls emphasize expanding loan volume and the longer-term tokenization opportunity; traders also speculate about short-covering and crypto-linked moves.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention after strong quarterly results highlighted record revenue and its first positive adjusted EBITDA, driven largely by Quake AI and its GPU-cloud business. Bulls see evidence that the AI infrastructure pivot is gaining traction and tout high short interest, while skeptics point to financing needs, potential data-center delays and continuing losses.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes FDA review of its sonelokimab application for hidradenitis suppurativa is the dominant catalyst, with traders focused on the filings acceptance and review timeline. Bulls point to the drugs clinical results and potential strategic value, while skeptics emphasize regulatory and competitive risks and worry that launching independently could require more capital.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Q3 results and guidance are the main focus, with traders weighing order and revenue growth against losses, execution, and dilution concerns. High reported short interest fuels squeeze hopes, while skeptics warn of a disappointing print; the Digital Bat drone order is cited as a growth signal, though some traders question the lack of disclosed value.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is drawing attention over ongoing generic-patent litigation involving Lupkynis, as repeated court extensions keep investors focused on the timing of possible settlements. Some traders speculate a resolution could be approaching, while others are frustrated by the delays and the companys limited communication.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

CoreWeaves strong results and raised outlook have revived confidence in AI-cloud demand, lifting Nebius shares ahead of its own Q3 report. Traders are split between expecting more upside and worrying the rally has priced in good results, with execution, capacity expansion and funding key points of debate.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Traders are focused on whether Strategy will be excluded from MSCI indexes under new rules for crypto-heavy companies, with bears warning of index-driven selling and bulls arguing the risk is already priced in or would have limited long-term impact. The debate is compounded by Bitcoin weakness and concerns about Strategys share dilution.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

A broader tech and fintech selloff, amid worries about rates and market volatility, has weighed on SOFI and revived complaints that it is lagging peers and giving back post-earnings gains despite strong results and raised guidance. Bulls point to business growth and profitability, while bears remain concerned about rate sensitivity, valuation and past dilution.

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Clorox Co.

Cloroxs Q1 earnings and revenue beat has supported bullish attention, alongside a sharp share-price rebound and unusually call-heavy options activity. Traders are also discussing a possible takeover, but the European-investor and buyout chatter remains unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trio-Tech Upgraded to Outperform on Backlog Growth & Strong Liquidity

TRT's upgrade to Outperform reflects growing backlog, automotive semiconductor expansion, stronger liquidity, improving cash flow and signs of IE recovery.

Trio-Tech Plunges More Than 64% in 6 Months: How to Play the Stock?

TRT's AI- and EV-driven testing demand, new burn-in contracts and expanded Malaysia capacity support growth, while an unfavorable revenue mix and higher costs pressure margins.

Trio-Tech International Secures New $4.45 Million Three-Year Burn-in Equipment Contract From Automotive Semiconductor Customer

Trio-Tech International (NASDAQ: TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced it has secured a new three-year contract valued at approximately $4.45 million to provide burn-in testing equipment and...

Trio-Tech Stock Plunges Post Q4 Earnings Despite Strong Revenue Growth

TRT's fourth-quarter fiscal 2026 revenue growth is driven by semiconductor testing demand, but margin pressure and higher operating expenses weigh on profitability.

Trio-Tech Reports 72% Fiscal 2026 Revenue Growth, Driven by Continued AI and Automotive Semiconductor Momentum

Trio-Tech International (NASDAQ: TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced financial results for its fourth quarter and fiscal year ended June 30, 2026. Trio-Tech International Chairman and CEO S.W...

TRT vs. ASYS: Which Semiconductor Equipment Stock Is the Better Buy?

Trio-Tech and Amtech serve distinct semiconductor equipment markets, but which stock is better positioned to create long-term shareholder value? Let's dive in.

Trio-Tech International Secures Three-Year Automotive Semiconductor Burn-In Contract With $4.7 Million Minimum Commitment

Trio-Tech International (NASDAQ: TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced it has secured a three-year production burn-in contract with a new automotive semiconductor customer across Europe and North...

Geospace Plunges Nearly 42% in 3 Months: How to Play the Stock?

GEOS is facing weak demand, PRM timing uncertainty and cash flow pressure, but security programs, cost cuts and seismic opportunities offer growth potential.

Trio-Tech Stock Jumps Nearly 122% in 6 Months: What's Behind the Rally?

TRT's AI- and EV-driven testing momentum, follow-on BIB orders and added Malaysia capacity support growth, while a weaker revenue mix pressures margins.

TRT vs. INTT: Which Semiconductor Testing Stock Is the Better Buy?

Trio-Tech and InTest ride on different testing and process technology tailwinds, but which looks more compelling now? Let's dive in.

This account has been verified as an official TRT representative.

Verified Account

Trio Tech International

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Cannabis, Psychedelics, And AI Stocks Are Wall Street’s Biggest Winners This Week

Equity

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>While the S&amp;P 500 closed up about 0.8% on Friday, the Nasdaq Composite rose 1.63%.&nbsp;</li><li>Trump announcements and solid corporate earnings drove significant rallies this week.</li></ul>U.S. equities closed out a highly active week on Friday, with the S&amp;P 500 and Nasdaq Composite ending the week near all-time highs, supported by strong earnings in the chipmaking and AI space, while policy support for cannabis and psychedelic research drove a few mid and small-cap pharma stocks higher.While the S&amp;P 500 closed up about 0.8% on Friday, marking its fourth consecutive week of gains, the Nasdaq Composite rose 1.63%. &nbsp;The following stocks clocked the highest gains this week:Akanda Corp. (<a href="https://stocktwits.com/symbol/AKAN">AKAN</a>): Shares of Akanda exploded this week, surging more than 300% after the Trump administration advanced plans to reclassify marijuana as a Schedule III drug. The broader cannabis sector ignited on the policy shift, and AKAN recorded single-day gains as high as 214%.Enveric Biosciences (<a href="https://stocktwits.com/symbol/ENVB">ENVB</a>): ENVB shares rocketed higher early in the week after President Trump’s executive order directing federal agencies to accelerate research and approval pathways for psychedelic therapies. The small-cap developer of psychedelic medicines for mental health surged more than 100% in a single session as investors bet on faster regulatory tailwinds in the sector. The company clocked its best week ever.MaxLinear (<a href="https://stocktwits.com/symbol/MXL">MXL</a>): MXL climbed sharply after the semiconductor company delivered a strong first-quarter earnings beat on Thursday and issued upbeat guidance that highlighted robust demand for its optical and connectivity chips in AI data centers. Revenue rose 43% year-over-year, beating estimates, and the raised outlook for the current quarter sent shares surging more than 75% in Friday’s session. The stock closed 130% higher this week, marking its best week to date.Trio-Tech International (<a href="https://stocktwits.com/symbol/TRT">TRT</a>): TRT stock soared as much as 67% on Thursday to a new all-time high as momentum traders piled into the stock. The company provides reliability testing services and specialized equipment that help chipmakers validate and stress-test products before they reach customers amid an overall increase in chip demand driven by AI infrastructure and data centers. The stock closed at $16.52 on Friday, after opening at just $7.05 at the week’s onset.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/arwr-rallies-this-week-as-europe-edges-closer-to-redemplo-approval-amid-analyst-optimism/cZBhLOHRecF">ARWR Rallies 7% This Week As Europe Edges Closer To Redemplo Approval Amid Analyst Optimism</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of GNTX rise on Friday (Representative image: Getty Images)

AKAN, ENVB, MXL, and TRT were the biggest gainers in the week ended April 24. 

Akanda Corp

Enveric Biosciences Inc

MaxLinear Inc

Yes, by year-end

Yes, but not this year

No, he stays as CEO

He steps down on his own

Do you think Jensen Huang will be removed as Nvidia’s ($NVDA) CEO?

Stocktwits

Do you think Jensen Huang will be removed as Nvidia’s (

Current Price	$5.26
Prev Close	$4.83
Open	$5.13
Dividend Yield	0.00%
50-Day Moving Average	$7.11
Beta	0.90
Avg. Volume	160,962.69
PE Ratio	-581.33

52-Week High	$21.38
52-Week Low	$3.25
Market Capitalization	$49.88M
EPS (Annual)	-$0.0038
Price to Book	1.11
Revenue Per Employee	$66,178.65

Feed

News

Sentiment

Fundamentals

Info

TRT Fundamentals